EluNIR

Ridaforolimus Eluting Coronary Stent System

  • Excellent clinical outcomes
  • Redefining deliverability with a new spring tip
  • Low footprint cobalt-chromium design
  • Optimal conformability and vessel support
  • Elastomeric coating and outstanding surface integrity
  • Eluting Ridaforolimus, a high therapeutic index limus drug

EluNIR – Elastomeric Drug Eluting Stent

EluNIR is FDA approved, CE Marked and PMDA approved (44mm lengths is not approved in the United States). For information on other countries please contact Medinol.

For more information about the product:

INSTRUCTIONS FOR USE
Contact Us

EluNIR First-In-Patient Implantation

Dr. Alaide Chieffo, MD; Dr. Francesco Giannini, MD

The first implantation of the EluNIR elastomeric drug-eluting stent. A complex case involving a flow-limiting lesion in a native coronary artery post an extremely tortuous LIMA bypass.

DOWNLOAD CASE STUDY

EluNIR DES in a Challenging Case

Antonio Colombo, MD, Francesco Giannini, MD; Columbus Clinic Center, Milan, Italy

A challenging case of implantation of two EluNIR elastomeric drug-eluting stents in a highly calcified and tortuous lesion post bypass surgery.

DOWNLOAD CASE STUDY

Flexx²
Deliverability

  • Purposefully designed spring tip for superior deliverability in challenging anatomies
  • Enhanced pushability and flexibility
  • The tapered spring tip was designed to closely track the guidewire and eliminate flare-out and buckling common to plastic tips
  • The only radiopaque tip, enabling visualization of the catheter-tip location during procedure
  • Reinforced hypotube for better hub-to-tip force transfer, enabling to navigate through tortuous anatomy without kinking
Flexx²

Designed for superior deliverability and crossability

Excellent Flexibility & Pushability – Flexible spring tip, designed to eliminate flare-out and buckling. Low true-entry-profile

Tip Visibility – The only radiopaque tip

Superior Crossability – of difficult lesions, calcifications and implanted stents

Spring Tip demonstrates best-in-class combination of Pushability and Conformability

Watch Dr. Kobi Richter, Founder and CTO of Medinol, discussing deliverability challenges

Stent Length
mm81215172024283338
2.25LUN225L08USLUN225L12USLUN225L15USLUN225L17USLUN225L20USLUN225L24USLUN225L28USLUN225L33US
2.50LUN250R08USLUN250R12USLUN250R15USLUN250R17USLUN250R20USLUN250R24USLUN250R28USLUN250R33US
2.75LUN275R08USLUN275R12USLUN275R15USLUN275R17USLUN275R20USLUN275R24USLUN275R28USLUN275R33USLUN275R38US
3.00LUN300R08USLUN300R12USLUN300R15USLUN300R17USLUN300R20USLUN300R24USLUN300R28USLUN300R33USLUN300R38US
3.50LUN350R08USLUN350R12USLUN350R15USLUN350R17USLUN350R20USLUN350R24USLUN350R28USLUN350R33USLUN350R38US
4.00LUN400R08USLUN400R12USLUN400R15USLUN400R17USLUN400R20USLUN400R24USLUN400R28USLUN400R33USLUN400R38US

Flexx²
Deliverability

  • Purposefully designed spring tip for superior deliverability in challenging anatomies
  • Enhanced pushability and flexibility
  • The tapered spring tip was designed to closely track the guidewire and eliminate flare-out and buckling common to plastic tips
  • The only radiopaque tip, enabling visualization of the catheter-tip location during procedure
  • Reinforced hypotube for better hub-to-tip force transfer, enabling to navigate through tortuous anatomy without kinking
Flexx²

Designed for superior deliverability and crossability

Excellent Flexibility & Pushability – Flexible spring tip, designed to eliminate flare-out and buckling. Low true-entry-profile

Tip Visibility – The only radiopaque tip

Superior Crossability – of difficult lesions, calcifications and implanted stents

Spring Tip demonstrates best-in-class combination of Pushability and Conformability

Watch Dr. Kobi Richter, Founder and CTO of Medinol, discussing deliverability challenges

WiZeCell
Stent Design

  • Low footprint cobalt-chromium design with ultra-narrow 40µm struts
  • Best In Class Scaffolding: adaptive cell size designed for optimal scaffolding and uniform drug dosing while preventing tissue prolapse
  • Excellent conformability in curved sections even during myocardial contractions
  • low crossing profile and flexibility for improved deliverability
  • Optimized side branch access
WiZeCell

Low footprint variable width design

40µm ultra narrow struts provides flexibility and conformability

Optimal scaffolding area provides uniform support and drug elution and prevents tissue prolapse

72µm struts provides excellent radial strength

Natural vessel curvature and myocardial contractions test the limits of stent design and scaffolding integrity.
EluNIR’s optimized cell size ensures uniform scaffolding and prevents tissue prolapse and strut overlap.

EluNIR

Competitor A

Competitor B

Competitor C

 

Note how other stents enable large openings, contributing to tissue prolapse and potentially restenosis.

 

eDES Coating

  • The first and only elastomeric* Drug Eluting Stent (eDES™)
  • exceptional surface quality
  • long term coating integrity
  • Comprehensive and controlled drug elution

*Elastomer – high elasticity polymer

eDes Coating
  • Medinol purposefully designed EluNIR’s coating for high performance and endurance.
  • EluNIR’s elastomeric coating maintains long-term surface integrity and enables predictable, uniform release of a limus drug to the vessel wall.
  • Improved surface quality and long term coating integrity may promote clinical advantages such as more uniform drug elution, better endothelialization, lower inflammation, lower ST and restenosis rates.

Images of EluNIR before and after drug elution. Notice the coating quality:

Elastomeric Coating

Crimped

Expanded

After Elution

  • Polymer coatings of other drug eluting stents often present surface deformations, webbing, cracking and peeling
  • These surface imperfections were associated with inflammation and thrombogenicity and may also result in non-uniform drug release1

Images of commercially available drug eluting stents before and after drug elution. Notice the damaged coating:

1 Basalus et al., Eurointervention 2013; 9:302-305

Watch Dr. Kobi Richter, Founder and CTO of Medinol, in how EluNIR is coated

The Making of EluNIR